We have advised Orano, a French multinational nuclear fuel cycle corporation, on the acquisition of Inevo, an engineering specialist in the health-pharmaceutical and biotechnology sectors, by its subsidiary Orano Projets.
Specialising in the engineering of processes involving solids, liquids and gas, for the healthcare, pharmaceuticals, fine and speciality chemicals, biotechnology and cosmetics sectors, Inevo works on industrialisation and optimisation studies, as well as on diagnostics in process engineering and simulations based on predictive models using artificial intelligence. Inevo employs around fifty people located in Lyon, Rouen and Grasse.
This acquisition will enable Orano Projets to strengthen its presence in the process industries market, in particular via the deployment of digital and AI solutions firmly anchored in unique specialist expertise and industrial experience.
Orano Projets, with its 1,600 employees worldwide, is strengthening its capacity with Inevo to respond to its customers' large-scale projects, from the upstream phases of R&D and pilot development, through the phases of completion of turnkey projects and optimisation of industrial performance for sites in operation.
